Mette Gyldenløve

Mette Gyldenløve is a Clinical Associate Professor at the Department of Clinical Medicine, University of Copenhagen, and a department physician at Gentofte Hospital (Herlev and Gentofte Hospital) specializing in Dermatology and Venereology. She holds a dual appointment between the Capital Region of Denmark and the University of Copenhagen, bridging clinical practice and academic research.

Her research centers on inflammatory skin diseases, with dominant focus on psoriasis (100% fingerprint prevalence), hidradenitis suppurativa, and acne. She investigates pharmacological interventions like roflumilast, examining drug safety, efficacy, and impacts on patient-reported outcomes, cardiometabolic parameters, and immunological mechanisms. Her work spans clinical trials, real-world cohort studies, and molecular investigations into cytokine signaling and immune cell infiltration.

Recent publications (2024-2025) reveal a concentrated research trajectory on roflumilast for psoriasis and hidradenitis suppurativa, including mechanistic studies on CD4+ T-cells and neutrophils, cardiometabolic effects, and practical clinical applications. She also contributes to dermatological knowledge through reviews on acne and tropical skin conditions.

Dr. Gyldenløve maintains active industry collaborations, receiving a travel grant from Sanofi (2024) and personal fees from Galderma Nordic AB (2023), reflecting engagement with pharmaceutical research in her field.